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Progenitornerate auditory hair cells (HCs) after injury. During regeneration, mature non-
sensory supporting cells (SCs) leave quiescence and convert into HCs, through non-mitotic or mitotic
mechanisms. During embryogenesis, Notch ligands from nascent HCs exert lateral inhibition, restricting HC
production. Here, we examined whether Notch signaling (1) is needed in mature birds to maintain the HC/SC
pattern in the undamaged auditory epithelium or (2) governs SC behavior once HCs are injured. We show
that Notch pathway genes are transcribed in the mature undamaged epithelium, and after HC injury, their
transcription is upregulated in the region of highest mitotic activity. In vitro treatment with DAPT, an
inhibitor of Notch activity, had no effect on SCs in the undamaged epithelium. Following HC damage, DAPT
had no direct effect on SC division. However, after damage, DAPT caused excessive regeneration of HCs at the
expense of SCs, through both mitotic and non-mitotic mechanisms. Conversely, overexpression of activated
Notch in SCs after damage caused them to maintain their phenotype and inhibited HC regeneration.
Therefore, signaling through Notch is not required for SC quiescence in the healthy epithelium or to initiate
HC regeneration after damage. Rather, Notch prevents SCs from regenerating excessive HCs after damage.
© 2008 Elsevier Inc. All rights reserved.Introduction
In mammals, production of mechanosensory hair cells (HCs) in the
cochlea is completed before birth. Any subsequent loss of auditory HCs
is not corrected, resulting in permanent hearing loss. In contrast, many
non-mammalian vertebrates readily regenerate HCs into adulthood
(reviewed in Stone and Cotanche, 2007). A central problem in hearing
research is to understand the mechanisms that dictate whether or not
lost HCs are replaced.
Hair cell regeneration has been most thoroughly studied in birds.
In the avian auditory epithelium (basilar papilla, or BP), progenitors of
new HCs are supporting cells (SCs), which reside amongst HCs. All SCs
of the BP are formed and differentiated by hatching (Katayama and
Corwin, 1989; Ginzberg and Gilula, 1979; and Goodyear et al., 1996).
After hatching, SCs normally remain quiescent (Oesterle and Rubel,
1993), but if HCs are destroyed, SCs give rise to newHCs in two distinct
ways. Initially, some SCs convert into HCs without dividing, a process
termed direct transdifferentiation (Adler and Raphael, 1996; and
Roberson et al., 1996). A couple of days later, additional SCs divide,
and their progeny differentiate into HCs or SCs (Corwin and Cotanche,irginia Merrill Bloedel Hearing
nd Neck Surgery, University of
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and Stone and Cotanche, 1994). In this manner, a balanced mixture of
HCs and SCs is reestablished, and thereafter, the system returns to
quiescence.
Little is known about the signals that regulate the behavior of
mature SCs, in quiescence or after HC loss. Clues may be derived from
embryogenesis. In all vertebrates, sensory patches of the inner ear
originate as groups of progenitor cells that then diversify to form a
precisely patterned mosaic of HCs and SCs. A critical regulator of this
process is the Notch pathway. Notch signaling depends on transmem-
brane ligands of the Delta or Serrate/Jagged family, expressed on
signal-delivering cells, which bind to Notch receptors in signal-
receiving cells (reviewed in Lewis, 1996). This triggers a series of
gamma-secretase-dependent cleavages that release the intracellular
fragment of Notch, called NICD. NICD translocates to the nucleus and
stimulates expression of transcriptional effectors of the Hes/her/E(spl)
family, which in turn regulate the expression of downstream target
genes. Through this mechanism, a cell expressing a Notch ligand and
differentiating into a particular cell type can inhibit its neighbors from
doing likewise, a phenomenon called lateral inhibition (Artavanis-
Tsakonas et al., 1995; Kageyama et al., 2005; and Lewis, 1998).
Many studies have shown that lateral inhibition regulates the
embryonic production of HCs (reviewed in Kelley 2006). Newly
formed HCs express the proneural gene Atoh1, which is required for
HC speciﬁcation and/or differentiation (Bermingham et al., 1999; and
Table 1
Primers for qRTPCR
Gene 5′ Sequence 3′ Sequence
Notch1 CACCGAAGGTTTCTCAGGTGT GGCAGAGGCAGGTGAAGG
Notch2 GCTGCTCAGGCAATCAAGG TGCCACGGCGAGTAGGTAG
Serrate1 TGCCAGACGGTGCTAAGTG TCGAGGACCACACCAAACC
Serrate2 TGGAAGGTTGGATGGGAGA CCTGGGTAGCGGACACACT
Delta1 GCAGGAGTGAAACGGAGACC CGATGACGCTGATGGAGATG
Cath1 AACCACGCCTTCGACCAG TGCAGCGTCTCGTACTTGGA
Hes5 TATGCCTGGTGCCTCAAAGA GCTTGTGACCTCTGGAAATGG
Hes6 GATTCCAAAGTGGGCCTTGA CTCGCAGGTGAGGAGAAGGT
MINT GAGATCCATCCGCCCAGAC ACAGCCCATCGAACACAGG
Lunatic fringe GAAGAGCTGCGGGAGGAAG GCTCCACCATGAGCACCAG
MyosinVI TTCCTGCCGAAGAGGACAG TGTGGAGGAGAGTGGCTTCA
β-Tectorin GGCCCTGCACTCCAAATAAA AGCTGATTGACCTCCCATCC
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(Dll1) and Serrate2/Jagged2 (Adam et al., 1998; Lanford et al., 1999;
Lanford et al., 2000; Morrison et al., 1999; and Zine and de
Ribaupierre, 2002). These ligands activate Notch in neighboring
cells, stimulating Hes1 and Hes5 expressions. Hes1 and/or Hes5
repress the HC fate (Zheng et al., 2000; and Zine et al., 2001),
inhibiting expression of Atoh1 and Dll1. As a result, cells contacting
HCs remain as progenitors or, later, differentiate as SCs (Woods et al.,
2004; Yamamoto et al., 2006; Takebayashi et al., 2007; and Hayashi
et al., 2008). On the other hand, disruption of Notch signaling in the
embryonic inner ear results in excessive production of HCs (Haddon et
al., 1998; Lanford et al., 1999; Zine et al., 2001; Brooker et al., 2006;
Kiernan et al., 2005). Lateral inhibition via Notch also appears to
regulate progenitor cell division in developing epithelia of the inner
ear (Kiernan et al., 2005; and Takebayashi et al., 2007) and during
regeneration in lateral line neuromasts (Ma et al., 2008).
Although Notch-pathway genes are expressed in inner ear
epithelia post-embryonically (Stone and Rubel, 1999), the speciﬁc
roles for Notch in maintenance and repair of the HC-SC pattern in
inner ear epithelia capable of HC regeneration have not been studied.
Here, we examined the expression of several Notch pathway
components in the mature chicken BP, in the normal state and during
regeneration after HC loss, and we tested the consequences of
blocking Notch signaling in each condition. We found that Notch
activity is not required to maintain mature SCs in quiescence, to
reactivate progenitor cells (SCs) after HC injury, or to directly regulate
progenitor cell (SC) division after HC injury. Instead, Notch activity
modulates the number of SCs that directly transdifferentiate into HCs,
as well as the number of SC progeny that differentiate into HCs, after
damage has occurred, in a region-speciﬁc manner.
Materials and methods
Animal care and treatment
Fertile eggs of chickens (Gallus gallus, White Leghorn) were
received from Hyline International (Graham, WA). Post-hatch chicks
between days 5 and 10 received Gentamicin (subcutaneous,
1×250 mg/Kg on 2 consecutive days, Sigma-Aldrich, St. Louis, MI)
and/or bromodeoxyuridine (BrdU; intraperitoneal, 100 mg/Kg, Sigma-
Aldrich, St. Louis, MI) as per Stone and Rubel (2000). Chickens were
euthanized by intraperitoneal Nembutal overdose or decapitation,
conforming to AALAC standards. Tissue was dissected and ﬁxed in
buffered 4% paraformaldehyde (Stone and Rubel, 1999; Stone et al.,
2000).
Tissue labeling
Proteins were detected in whole-mount cochlear ducts using
indirect immunolabeling. Rabbit anti-Atoh1 antibody was received
from Dr. Jane Johnson (University of Texas Southwestern Medical
Center). Mouse anti-HCA, anti-SCA, and anti-β-tectorin-precursor-like
antibodies were received from Dr. Guy Richardson (University of
Sussex, UK). Rabbit anti–MyosinVI antibody was purchased from
University of California San Diego (Dr. Tama Hasson) or Proteus
Biosciences (Ramona, CA). Mouse anti-GFP antibody was purchased
fromMolecular Probes (Eugene,OR).Mouse or rat anti-BrdUantibodies
were purchased from BD Sciences (San Jose, CA), DAKO (Glostrup,
Denmark), or SeraLabs (West Sussex, UK). Rabbit anti-Caspase 3
antibodies were purchased from R and D Systems (Minneapolis, MN).
Secondary antibodies conjugated to ﬂuorophores (Cy3, Cy5, Alexa 488)
were purchased from Jackson ImmunoResearch Laboratories (West
Grove, PA) or Molecular Probes (Eugene, OR). Atoh1 immunolabeling
was performed as described in Cafaro et al. (2007). The TUNEL reaction,
with ﬂuorescent detection (Chemicon, Temecula, CA), was used to
detect dying cells in whole-mount cochlear ducts.mRNA was detected in whole-mount cochlear ducts using non-
radioactive in situ hybridization (ISH; Stone and Rubel, 1999; and
Henrique et al., 1995). Digoxygenin (DIG) or Fluorescein (FITC)-
conjugated riboprobes were synthesized from plasmids containing
fragments or complete cDNA of the following chicken genes: Serrate1,
Delta1, Notch1, Hes5.1 and Hes5.3 (obtained from Dr. Domingos
Henrique; University of Lisbon, Lisbon, Portugal, Fior and Henrique,
2005), Lunatic Fringe (Lnfg; obtained from Dr. Cliff Tabin, Harvard
University, Laufer et al., 1997), and Atoh1 (obtained from Fernando
Giraldez from Pompeu Fabra University, Barcelona, Spain, Pujades et
al., 2006). Riboprobes were detected using Alkaline Phosphatase-
conjugated anti-DIG antibody and NBT/BCIP substrate (Roche, India-
napolis, IN), or anti-DIG and anti-FITC antibodies conjugated to
horseradish peroxidase (HRP; Roche, Indianapolis, IN), and tyramides
labeled with Cy3 or FITC (TSA Plus ﬂuorescence system; Perkin Elmer,
Waltham, MA). Sense probes served as negative controls. For double-
ISH, specimens were hybridized with a mixture of DIG- and FITC-
labeled RNA probes that were detected sequentially. After revea-
ling the ﬁrst probe, specimens were incubated in Glycine/2N HCl
and washed before applying the second horse radish peroxidase-
conjugated antibody. Following ISH, some samples were processed for
immunolabeling with rabbit anti-serrate1 (Adam et al., 1998) and/or
mouse anti-BrdU (DAKO; Glostrup, Denmark) antibodies.
To examine gene/protein expression after in vivo Gentamicin
exposure, approximately 8 BPs were examined per time-point and
gene. To compare gene/protein expression in DMSO-treated (control)
and DAPT-treated BPs, at least 5 specimens from the same culture
batch were processed in parallel (2–3 culture runs were performed
per experiment).
Puriﬁcation of mRNA and preparation of cDNA
For each condition (control, 1 day post-Gentamicin, or 4 days post-
gentamicin), sensory epithelium (BP) from the proximal half of the
cochlear duct was isolated as described in Stone et al. (1996). For each
run (n=3 per condition), tissue from 22 cochlear ducts was
placed directly in RNeasy R1 Buffer (Qiagen, Valencia, CA) and stored
at −80 °C. RNA was isolated using the RNeasy Micro kit (Qiagen,
Valencia, CA). RNA quality and yield were conﬁrmed using a ND-1000
spectrophotometer (NanoDrop Technologies, Wilmington, DE). First-
strand cDNAwas synthesized using PowerScript Reverse Transcriptase
(Clontech, Mountainview, CA), diluted 1:20 in 10 mM Tris–HCl,
0.1 mM EDTA (pH 8.0), and stored at −20 °C.
Quantitative real-time polymerase chain reaction (qRTPCR)
For each qRTPCR run, approximately 60 ng of cDNA was used.
Ampliﬁcation was performed using an iCycler (BioRad, Hercules, CA).
Primer sets (Invitrogen, Carlsbad, CA; Table 1) were designed to have
comparable melt curves (Tm=60 °C). Samples lacking reverse
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Threshold cycle (Ct) was set at 300 relative ﬂuorescent units. β-actin
was conﬁrmed as a strong reference gene across control and
Gentamicin-treated samples using geNorm software (http://medgen.
ugent.be/~jvdesomp/genorm/).
To estimate changes in mRNA levels after Gentamicin treatment,
the 2−ΔΔCt methodwas used (Pfafﬂ, 2001; and Colebrooke et al., 2007).
For each sample, themRNA level of each target gene relative to β-actin
was estimated by calculating the DeltaCt, or ΔCt (Cttarget gene− Ctß-actin)
and then converting to 2−ΔCt. These values were averaged across
samples in a group (n=3), and statistical differences were examined
using ANOVA. To comparemRNA levels between experimental groups,
the ratio of the average 2−ΔCt for each treatment group relative to the
control group (2− ΔΔCt) was determined for each gene. This ratio
represents a fold change for each gene after damage.
Organ culture, DAPT treatment, and electroporation
Cochlear ducts were isolated, the tegmentum vasculosum was
removed, and organs were cultured free-ﬂoating in 500 µl of
Dulbecco's Minimal Essential Medium (Sigma-Aldrich, St. Louis, MI)
at 37 °C in 95% air/5% CO2. These drugs were added to media: 1% fetal
bovine serum (Atlanta Biologicals, Atlanta, GA), Penicillin/Streptomy-
cin (1% or 78 µM Streptomycin, Sigma-Aldrich, St. Louis, MI), 5-
bromo-2-deoxyuridine (BrdU, 1 µM, Sigma-Aldrich, St. Louis, MI), and
N-[N-(3,5-Diﬂuorophenacetyl-L-Alanyl)]-S-phenylglycine t-butyl
ester (DAPT, 1 µM–100 µM, Calbiochem #565770, San Diego, CA)
dissolved in dimethyl sulfoxide (DMSO, 0.1%–1%, Sigma-Aldrich, St.
Louis, MI). Half-volumes of culture media were exchanged daily. For
each experiment, at least 3 runs were performed. For each run, at least
6 organs were included for each experimental condition. Negative
controls for DAPT consisted of DMSO at concentrations matching
experimentals (0.1–1.0%).
After 2 days of culture in Streptomycin, some cochlear ducts were
electroporated with plasmid DNA. One of two plasmids driving
expression of the intracellular domain of the chicken Notch1 receptor
was used: pNICD-IRES-EGFP (Daudet and Lewis, 2005) or pCAB-NICD-
IRES-EGFP. As a control vector, we used pMES-IRES-EGFP (from Dr.
Catherine Krull, University of Michigan). All plasmids were delivered
at similar concentrations (2–4 µg/µl). Organs were placed in a 10-µl
drop of DNA (in TE buffer) on a plastic dish, and ﬁne tungsten
electrodes were placed on either side of the organ (approximately
1 mm apart), ﬂanking the inferior and superior cartilaginous plates.
Current was delivered using an ECM 830 BTX electroporator
(Genetronics) with the following parameters: 60–75 V, 60 ms
duration, 100 ms inter-pulse duration, and 6–8 pulses per train.
Current was delivered to three regions along the length of the BP
(proximal, middle, and distal). In each region, three current trains
were delivered, then the polarity was reversed, and three additional
trains were delivered. Following electroporation, organs were
returned to the incubator for 2 or 5 additional days; media were
replenished every 2 days.
Imaging and data analysis
Whole-mount cochlear ducts were imaged using laser scanning
confocal, wide-ﬁeld epiﬂuorescence, and/or bright-ﬁeld microscopy.
For qualitative analyses, at least 6 organs were examined for each
variable. For quantitative analyses, at least 3 organs were studied for
each variable; numbers are provided below. Data were statisti-
cally analyzed by ANOVA (Fisher's PLSD) using Statview; s.d.'s are
provided.
For quantitative analysis ofHes5 andBrdUdouble-labeling, 7 cochlear
ducts at 3dayspost-Gentamicin/2hpost-BrdUwere analyzed. Theentire
damaged region was scanned at 60×. Each clearly identiﬁable BrdU-
positive nucleus was scored as positive or negative for Hes5.To determine the fate of transfected cells, each cochlear duct was
analyzed at 40–60 ×on the confocal microscope. GFP-immunoreactive
(IR) cells in the BP were identiﬁed, and healthy-looking cells (those
lacking blebs, odd shapes, or other signs of damage) were chosen for
further analysis. Each GFP-IR cell was scored as MyosinVI-negative or -
positive and for whether its shape was more characteristic of a SC
(bipolar cell with long apical and/or basal processes) or HC (fusiform
or round in shape), or atypical of either cell type. For the pMES group,
we scored 138 GFP-IR cells (28 ﬁelds, 13 BPs), and for the pNICD group,
we scored 65 GFP-IR cells (23 ﬁelds, 15 BPs). For each ﬁeld, we
calculated the percentage of cells that were MyosinVI-negative or
MyosinVI-positive.
To quantify BrdU/MyosinVI or BrdU/Atoh1 labeling, between 3 and
4 BPs from each group (DAPT, DMSO) were imaged using confocal
microscopy at 60×. For each BP, two or three 41,209 µm2 regions
(proximal, mid-proximal, and/or middle) were analyzed. As a result,
approximately 8–13% of the lesion's area was analyzed. All sites were
situated halfway between the neural and abneural edges of the BP.
Z-series stacks were obtained by scanning from the lumenal surface to
the basal lamina. Counts were made off-line using ImageJ/Cell
Counter. For each BP, an average count was obtained by pooling data
from all sites. For BrdU counts, all BrdU-positive nuclei were included,
regardless of their MyosinVI or Atoh1 labeling. For counting
regenerated HCs, each MyosinVI-positive cell or Atoh1-positive cell
was scored as BrdU-positive or -negative.
Results
Several Notch pathway components are expressed in the quiescent
basilar papilla at low levels and are upregulated after damage
In a previous study (Stone and Rubel, 1999), we used ISH to
examine expression of Notch1, Delta1, and Serrate1 mRNA in mature
chicken BPs that were either undamaged or damaged with the
ototoxin, Gentamicin. Here, we expanded this analysis with a more
sensitive method, qRTPCR, to quantify the changes in sensory
epithelial expression of a larger set of Notch-related genes. We
examined the following transcripts: Notch1, Notch2, Delta1, Serrate1,
Serrate2, Hes5, Hes6, and Atoh1, as well as Lnfg (Haltiwanger, 2002)
and MINT (Kuroda et al., 2003), which encode two modulators of
Notch signaling. For reference, we also measured relative expression
of β-tectorin, which is abundant in supporting cells (SCs) (Goodyear
et al., 1996), and MyosinVI, which is expressed in hair cells (HCs)
(Hasson et al., 1997).
We analyzed control (undamaged) BPs and regenerating BPs at
1 day and 4 days post-Gentamicin. To induce HC damage, we injected
chicks with Gentamicin, once per day for 2 consecutive days, which
causes complete HC loss throughout the proximal half of the BP but
preserves HCs in the distal half (Figs. 1A, B) (e.g., Cafaro et al., 2007).
Since Gentamicin induces a reliable HC lesion only in the proximal half
of the BP, all qRTPCR analyses were performed on RNA extracted from
this region only.
The expression level for each Notch pathway transcript relative to
β-actin (2−ΔCt) is shown in Fig. 2A, as are expression levels for
reference genes β-tectorin and MyosinVI. In the control BP, in which
SCs are quiescent, β-tectorinwas slightly more highly expressed than
β-actin, and MyosinVI showed considerably lower expression. Notch1,
Notch2, and Serrate1 were the most strongly expressed Notch-
pathway genes, and Serrate2, Delta1, Atoh1, Hes5, Hes6, MINT, and
Lnfg were expressed at considerably lower levels.
By 1 day post-Gentamicin (measured from the ﬁrst injection),
direct transdifferentiation of SCs, but not SC division, is initiated in the
damaged area (Cafaro et al., 2007; Roberson et al., 2004; and Stone
et al., 1999). At this time, expression of Atoh1 mRNA was increased
roughly 5-fold over levels in undamaged BPs, reﬂecting the initiation
of HC production by direct transdifferentiation (Figs. 2A, B). A similar
Fig. 1. HC regeneration in the avian BP after short Gentamicin treatment. (A) HCs (stippling) are distributed throughout the undamaged BP. The neural side of the BP is indicated and
overlies the cochlear ganglion. (B) HCs are missing from the proximal BP at 4 days post-Gentamicin (no stippling). The zone of transition (TZ) between damaged and undamaged
epithelium is indicated. (C) Immunolabeling for MyosinVI (red) and BrdU (green) in the damaged BP, in the region shown in the rectangular box in B. The dotted line separates neural
and abneural regions. BrdU-positive cells are densest in the neural (upper) region, although regenerated HCs (MyosinVI-positive) are distributed throughout the neural-abneural
axis. HCs regenerated via mitosis have BrdU-labeled nuclei (thick arrow) and are densest in the neural side, while HCs regenerated via direct transdifferentiation have BrdU-negative
nuclei (thin arrow) and are most common in the abneural side. The two mechanisms of HC regeneration are diagrammed on the right side of C. (D) The time-course of mitotic and
non-mitotic regeneration is outlined. d =days; h=hours.
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In addition, expression of Hes5 was signiﬁcantly decreased compared
to controls (to approximately 1/3×). However, none of the other genes
in our analysis were signiﬁcantly changed (by a factor of 2 or more, up
or down) compared to controls at this time.
At 4 days post-Gentamicin, many SCs are dividing, additional SCs
continue to undergo direct transdifferentiation, and speciﬁcation of
post-mitotic cells as either HCs or SCs is underway (Figs. 1C, D) (Stone
and Rubel, 1999, 2000; and Stone et al., 1999). At this time, we saw
statistically signiﬁcant increases in the expression of several Notch-related genes relative to control BPs, including Notch1 (1.7×)
Delta1 (3.5×), Atoh1 (21.5×), Hes5 (2×), Hes6 (26×), and Lfng (4.7×)
(Figs. 2A, B). Changes in Notch2, Serrate1, Serrate2, and MINT were
seen, but they were not statistically signiﬁcant (pN0.05).
The early upregulation of Atoh1 at 1 day post-Gentamicin might be
taken as a sign that a Notch-mediated lateral inhibition has been
relieved following HC damage. However, our data show that this early
change in Atoh1 expression precedes changes in the expression of
Notch ligands, suggesting that the effect is triggered not by
disappearance of the ligands that activate Notch but by some other
Fig. 2. Differential expression of Notch pathway genes in the quiescent and regenerating chicken BP. Transcripts were quantiﬁed by qRTPCR, and data were analyzed using the 2−ΔΔCt
method. (A) The table shows mRNA expression for each target gene relative to β-Actin (2−ΔCt). Data were averaged across 3 samples for each condition; standard deviations (sd) are
shown. Genes showing signiﬁcant differences in each treatment group compared to controls (ANOVA; p ≤0.05) are highlighted in yellow. (B) The graph shows average fold changes in
mRNA between each treatment group and the control group (2−ΔΔCt), with error bars representing standard deviations. A value of 1 (line) represents no difference from control.
Asterisks indicate genes with signiﬁcant differences in 2−ΔCt in each treatment group compared to controls (ANOVA; p ≤0.05).
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our data at 4 days post-Gentamicin, that the Notch signaling pathway
becomes strongly upregulated, when both direct transdifferentiation
and mitotic regeneration of HCs are in full swing.
Expression of Notch pathway components in the damaged epithelium is
spatially patterned
To localize Notch pathway gene expression in control BPs and after
Gentamicin treatment, we performed whole-mount in situ hybridiza-
tion and immunocytochemistry. Results are shown in Fig. 3, with
panels A, F, K, and O illustrating the approximate region of the
proximal BP where images were taken. For reference, we included
images of MyosinVI (Figs. 3B, G) and BrdU (Figs. 3C, H) labeling to
illustrate the degree of HC retention and SC division, respectively, seen
in the proximal end of control and damaged samples. By 3–4 days
post-Gentamicin, all HCs have been extruded from the proximal end
of the BP, and SCs are actively dividing there, particularly in the neural
half of the BP.Our previous study using in situ hybridization showed that, in the
control, undamaged BP, transcripts for Notch1 and Serrate1 are
expressed in SCs, but Delta1 mRNA is not detected in any cell (Stone
and Rubel, 1999), which is consistent with our qRTPCR results. Further
analysis here showed that Serrate1 protein is abundant in SCs
throughout the control BP (Fig. 3D), but transcripts for Lnfg and
Hes5.3 are not detected (Figs. 3E, L). In contrast, Hes5.1-expressing
cells were diffusely scattered throughout the BP (Fig. 3M). Staining in
the lagena provided a positive control for these results. In the lagena, a
vestibular epithelium located in the distal end of the cochlear duct,
there is continual HC turnover, and Serrate1 protein and Hes5.3,
Hes5.1, and Lnfg mRNA were all strongly expressed there (data not
shown). From these ﬁndings, we infer that in the quiescent auditory
epithelium, some Notch pathway components are expressed and the
pathway may have a low level of activity.
At 3 days post-Gentamicin, Stone and Rubel (1999) showed that
expression of Serrate1 and Notch1 was not signiﬁcantly altered, but
Delta1 was highly upregulated throughout the area of HC loss, in a
salt and pepper pattern. Delta1 was transcribed in some S-phase cells
Fig. 3. Localization of Notch-related gene expression in the quiescent and regenerating chicken BP. All panels except the drawings in the left column showepiﬂuorescent or brightﬁeld
images of the proximal whole-mounted BP. The box in each drawing shows the region fromwhich images were taken for all panels in that row. Neural is toward the top, and proximal
is toward the left. Panels B–E and L–M show control, undamaged BPs, and panels G–J, N, and P–R show BPs at 3–4 days post-Gentamicin. (B, G) Immunolabeling for MyosinVI in
control (B) and damaged (G) BPs. (C, H) Fluorescent BrdU labeling (2-hour pulse/ﬁx) in undamaged BP (C) and in BP after damage (H). (D, I) Serrate1 immunoﬂuorescence in control
BP (D) and in BP after damage (I). In damaged BP, immunolabeling for Serrate1 increased after damage in the neural half of BP (I). In situ hybridization (ISH) shows low levels or no
expression of Lnfg (E) and Hes5.3 (L), and some Hes5.1 expression (M), in control BP. ISH shows upregulated expression of Lnfg (J), Hes5.3 (P), and Hes5.1 (Q) in neural BP after
damage. Simultaneous labeling with probes for Hes5.1 and Hes5.3 shows Hes5 upregulation in neural BP (R). (N) Triple labeling of Hes5′s (red), Delta1 (green), and DAPI (blue)
shows little co-localization of Hes5 and Delta1. Scale bar=60 µm for all panels, except in N, where scale bar=6 µm.
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they differentiate. In this study, we examined whether labeling for
Serrate1 protein or Lnfg, Hes5.1, or Hes5.3 mRNA was altered at 1 or
2 days post-Gentamicin relative to controls. As judged by ISH, none of
these Notch pathway components showed a signiﬁcant change at
these times, except for Lnfg mRNA, which was slightly upregulated
in the damaged region of some BPs (data not shown). However, at
3–4 days post-Gentamicin, all of these Notch pathway components
(Serrate1 protein and Lnfg, Hes5.3, and Hes5.1 mRNA) showed
signiﬁcant upregulation in expression, particularly in the neural
region of the BP (Figs. 3I, J, P, Q, R). This area has the highest level of
mitotic activity after damage (Fig. 3H) (Cafaro et al., 2007). Double-
labeling for Delta1 and Hes5 (using a cocktail of Hes5.1 and Hes5.3
probes) showed that Hes5-positive cells were typically Delta1-
negative, and vice-versa (Fig. 3N), indicating that Hes5-positive cells
were most likely SCs. No change in expression of any transcript or of
Serrate1 protein was seen in the distal, undamaged region after
Gentamicin treatment (data not shown). These ﬁndings demonstrate
that, by the time SC division is initiated, Notch activity has becomehighly upregulated in SCs in the region of cell division. This
upregulation may occur via Delta1 and/or Serrate1, which are also
upregulated in this region.
Cell proliferation is stimulated in parallel with expression of Notch
pathway components
After Gentamicin treatment, HC loss starts at the proximal end of
the BP and spreads distally over time. At 4 days post-Gentamicin, SCs
along the leading, distal edge of the lesion are undergoing the initial
phase of HC regeneration (direct transdifferentiation), while SCs in
more proximal regions are in later phases of regeneration, including
SC division (Cafaro et al., 2007). To determine which SC behaviors are
associated with increased Notch activity, we injected birds with BrdU
at 4 days post-Gentamicin and killed them 2 h later, to catch SCs in
S-phase. We then double-labeled BPs for BrdU and Hes5, Delta1, or
Serrate1.
In the middle of the damaged region (Figs. 4A–C), where Serrate1,
Hes5, and Delta1were strongly expressed, we sawmany BrdU-positive
Fig. 4. Spatial relationships of Serrate1, Hes5, and Delta1 expression and BrdU labeling. All panels show whole-mounted BPs at 4 days post-Gentamicin. The distal end is toward the
right, and the neural edge is toward the top. In all panels, BrdU labeling (red) is shown after a 2-hour BrdU pulse followed by immediate ﬁxation. Panels A and D also show Serrate1
protein labeling (green). B and E also show Hes5mRNA labeling (green). C and F also show Delta1mRNA labeling (green). (A–C) Images from the middle of the damaged region. (D–F)
Images from the transitional zone. Insets in B and C show larger magniﬁcations of labeling; arrowheads in C inset show cells double-labeled for BrdU and Delta1. In panels D–F, the
apical-most labeling for ISH or BrdU is indicated by an arrowhead or an arrow, respectively. Scale bar=15 µm for A–F and 7 µm for insets in B and C.
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level of Notch activation. However, whenwe scored BrdU-labeled cells
according to their level of Notch activation, as indicated by Hes5
expression, we found that most cells showed labeling for only one of
these two markers. Of 1574 BrdU-positive cells examined in 7 BPs, the
majority of BrdU-positive cells were Hes5-negative (Fig. 4B inset);
only 85 cells (5%) were Hes5-positive. Conversely, numerous BrdU-
labeled cells expressed Delta1 (Fig. 4C inset), conﬁrming a similar
observation by Stone and Rubel (1999) and indicating that their level
of Notch activation was low. These data show that dividing cells tend
to have low levels of Notch activity, as reﬂected by Hes5 transcription.
This suggests that 1) Notch activation is antagonistic toward SC re-
entry into the cell cycle or 2) some damage-induced signal other than
Notch activity provokes SC re-entry into the cell cycle and antagonizes
Hes5 expression.
Further analysis showed that Serrate1 and BrdU labeling shared a
similar boundary (Fig. 4D), suggesting that Serrate1 upregulation
occurs concurrently with SC re-entry into the cell cycle. In contrast,
upregulation of Hes5 (Fig. 4E) and Delta1 (Fig. 4F) was seen in regions
distal to Serrate1 upregulation, presumably along the leading edge of
HC damage. This pattern of expression mirrors that of Atoh1 protein
after an identical HC damage paradigm (Cafaro et al., 2007).
Inhibition of gamma secretase in undamaged auditory epithelium does
not trigger HC production
The expression of several Notch-pathway genes in the undamaged
BP raised the question of whether Notch signaling plays any part in
maintaining SCs in a quiescent state. To ﬁnd out, we maintained
cochlear ducts from post-hatch chickens in vitro in the presence of the
gamma-secretase inhibitor, DAPT, which prevented the release of the
activating intracellular fragment of Notch, the NICD (Dovey et al., 2001;
and Selkoe and Kopan, 2003). We compared the outcome of the DAPT
treatmentwith that seen after similar culture inDMSOcontrolmedium.
In initial experiments, cultures were maintained for 3 or 7 days
without Streptomycin or any other HC-damaging toxin, then ﬁxedand immunolabeled for MyosinVI to detect HCs (Hasson et al., 1997).
After 3 days of culture in DMSO control media, the morphology and
patterning of the original HCs were retained in middle (Fig. 5A) and
distal regions of the BP, but some HC damage and loss were evident
in the proximal area (Fig. 5B). This damage was likely due to
dissection or the lack of necessary trophic factors in culture media.
The appearance of the BP after a similar time in medium containing
100 µM DAPT was comparable in both regions (Figs. 5C, D),
indicating that DAPT, even at a high concentration, does not induce
HC damage or trigger regenerative processes such as conversion of
SCs into HCs.
In BPs cultured without Streptomycin for 7 days with DAPT (10 or
100 µM) or DMSO, original HCs in middle and distal parts of the BP
were preserved (Fig. 5E, 10 µM DAPT is shown). In addition, these
regions showed little evidence of new HC production after treatment
with DMSO or DAPT, at either concentration (Figs. 5E, F). Newly
differentiated HCs would have emerged in either the HC or SC nuclear
layer as MyosinVI-positive cells that were smaller and more fusiform
than the original HCs (e.g., see Stone and Rubel, 2000). These ﬁndings
demonstrate that inhibition of gamma secretase does not alter the
normal state of the mature BP when original HCs are intact. Similar
experiments accompanied by continuous BrdU labeling demon-
strated that DAPT treatment in organs not exposed to Streptomycin
does not trigger any discernible SC proliferation in undamaged areas
(data not shown). Therefore, we conclude that, although several
Notch pathway components are expressed in the mature undamaged
BP, Notch signaling (at least, the canonical, gamma secretase-
dependent type) is not responsible for maintaining SCs in a quiescent
state.
The appearance of the proximal BP at 7 days in vitro, where culture
conditions had caused nearly complete HC loss in both DMSO controls
and DAPT-treated BPs, provided a marked contrast. Here, signiﬁcant
numbers of original HCs had died and been extruded (Figs. 5G, I). In
BPs treated with DMSO (Figs. 5G, H), occasional regenerated HCs were
seen in regions of HC loss. In contrast, in BPs treatedwith 10 or 100 µM
DAPT, much higher numbers of regenerated HCs were seen in the
Fig. 5. In vitro DAPT treatment does not alter HC regeneration in undamaged epithelium. Panels A–L show Z-projected confocal stacks of MyosinVI labeling (red) in the middle or
proximal region of the BP (see Fig.1), after DMSO or DAPT treatment. The plane of focus, in themore lumenal HC nuclear layer (HCL) or in the deeper region, the SC nuclear layer (SCL),
is indicated. Concentrations for DAPT are 100 µM for C, D, and L and 10 µM for E, F, I, and J. DMSO concentrations were matched for comparisons. Panels A–D show BPs cultured for
3 dayswithout Streptomycin. The degree of spontaneous HC loss is lower in the middle region (A, C) than in the proximal region (B, D). DAPT caused no increase in HC death in either
region compared to DMSO (compare A with C, and B with D). Panels E–J show BPs cultured for 7 days without Streptomycin. The same ﬁeld is shown in E and F, in G and H, and in I
and J, with E, G, and I focused on the HCL and F, H, and J focused on the SCL. DAPT did not promote new HC production in the middle region (E, F), which retained most original HCs.
However, in the proximal region, where signiﬁcantly fewer original HCs survived, DAPT caused increased HC regeneration (I, J) compared to DMSO controls (G, H). Arrows in G and I
point to surviving original HCs (large cells, nuclei in HCL). Arrowheads in H–J point to newly regenerated HCswhose necks protrude into the HCL (I) andwhose nuclei reside in the SCL
(H, J) K, L. In BPs maintained for 3 in vitro with Streptomycin, similar levels of drug-induced HC loss were seen in BPs treated with DMSO or DAPT. M. BPs cultured for 8 days (2 days
plus Streptomycin then 6 days minus Streptomycin, with DMSO and BrdU present for the last 6 days) have numerous MyosinVI-positive regenerated HCs (red). BrdU labeling (green)
indicates new cells that were formed by mitosis. Insets show a BrdU-positive cell generated though mitosis (left) and a BrdU-negative cell regenerated via direct transdifferentiation
(right). Scale bar (in A)=20 µm for A–J, 40 µm for M, and 10 µm for M insets.
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(Figs. 5I, J, 10 µM DAPT is shown). Therefore, although DAPT treatment
is not sufﬁcient to promote SCs to leave quiescence when local HCs
remain intact, DAPT treatment does cause SCs to form excessive new
HCs when high numbers of local HCs are damaged or missing. This
ﬁnding is examined in more detail below.Inhibition of gamma secretase leads to increased Atoh1 and Delta1
expression and decreased Hes5 expression after drug-induced HC loss
Next, we tested whether inhibition of gamma secretase with DAPT
alters the regenerative response to HC loss caused by damage with an
ototoxic drug, as predicted if Notch signaling regulates SC behavior.
Fig. 6. In vitro DAPT treatment alters transcription of Notch-related genes in drug-damaged BPs. Images were taken from BPs cultured for 3 days (2 days plus Streptomycin then 1 day
minus Streptomycin), with either DMSO or DAPT present for the entire culture period. Images show the middle region, with the neural half toward the top, and the distal end toward
the right. (A–D) ISH for Atoh1 in BPs treated with 0.5% DMSO (A), 1 µM DAPT (B), 10 µM DAPT (C), or 50 µM DAPT (D). (E, F) ISH for Delta1 in BPs treated with 0.5% DMSO (E) or 50 µM
DAPT (F). (G, H) ISH for Serrate1 in BPs treated with 0.5% DMSO (G) or 50 µM DAPT (H). I, J. ISH for Hes5′s in BPs treated with 0.1% DMSO (I) or 10 µM DAPT (J). Scale bar in A= 15 µm
(applies to A–D), and scale bar in E=15 µm (applies to E–J).
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2 days to kill HCs and were then maintained in Streptomycin-free
media for one additional day. MyosinVI labeling was used to detect
HCs. In contrast to the mild and locally restricted damage seen in
untreated cultures, Streptomycin caused near-complete loss of HCs
from all regions of the BP by 3 days in vitro, regardless of whether or
not culture media contained DAPT (Figs. 5K, L). SCs had entered the
cell cycle by 3 days, and like in vivo, SC division was heaviest in the
neural region (data not shown). At this time, new HCs had not
differentiated to the degree of expressing MyosinVI protein. However,
by 8 days (2 days plus Streptomycin then 6 days minus Streptomycin),
numerous MyosinVI-positive regenerated HCs were evident through-
out BPs cultured in DMSO (Fig. 5M). Continuous BrdU labeling showed
that some HCs regenerated in vitro were BrdU-negative and therefore
formed by direct transdifferentiation, while others were BrdU-positive
and therefore formed via mitosis, resembling HC regeneration in vivo.
To test how Notch activity modulates drug-induced HC regenera-
tion, organs were ﬁrst cultured for 2 days with Streptomycin followed
by 1 day without Streptomycin, with DAPT (at 1, 10, or 50 µM) or
DMSO (matching concentrations) present in the culture media for the
whole period. In standard Notch-mediated lateral inhibition, Notch
activation cell-autonomously inhibits a cell's differentiation toward
the primary fate and its ability to express Notch ligands. Therefore,
DAPT blockade of Notch activation should evoke increased expression
of the pro-HC transcription factor, Atoh1, and the Notch ligand, Delta1.
We tested this hypothesis, using ISH to detect Atoh1 and Delta1
transcripts.
In Streptomycin-treated organs cultured 3 days with DAPT
(Figs. 6B–D), Atoh1 transcripts were highly increased relative to
DMSO controls (Fig. 6A). The degree of Atoh1 upregulation in damaged
BPs appeared to correlate directly with DAPT concentration; limited
differences were seen with 1 µM DAPT (Fig. 6B), but striking effects
were clear with 10 µM (Fig. 6C) or 50 µMDAPT (Fig. 6D). Similar results
with DAPT were seen in the lagena (data not shown). In addition,
treatmentwith DAPT (50 µM) caused an elevation inDelta1 transcripts
over control levels (Figs. 6E, F). In another set of experiments, we
found that application of N-(R)-[2-(hydroxyaminocarbonyl)methyl]-
4-methylpentanoyl-l-naphthylalanyl-l-alanine-2-aminoethyl amide
(TAPI-1), a drug that inhibits a second enzyme required for Notch
cleavage and activation (TNF-alpha converting enzyme, or TACE; Brouet al., 2007), to Streptomycin-treated BPs for 3 days also caused a
signiﬁcant upregulation in Atoh1 transcription compared to negative
control (DMSO) in a dose-dependent manner (Supplemental Fig. 2).
However, in contrast to the DAPT-induced upregulation of Atoh1 and
Delta1, we noted no difference in Serrate1 mRNA expression between
DMSO- and DAPT-treated cultures (Figs. 6G, H), implying Serrate1
transcription is not regulated by Notch activity in the regenerating BP.
Activation of Notch promotes transcription of Hes genes. We tested
if inhibition of gamma secretase with DAPT leads to decreased Hes5
transcription in the regenerating BP, using a cocktail of probes for
Hes5.1 and Hes5.3 transcripts. In Streptomycin-damaged cochlear
ducts cultured in DMSO control media for 3 days, expression of Hes5
genes was elevated compared to quiescent organs (compare Figs. 6I
and 3L, M), similar to what is seen in vivo after Gentamicin treatment
(compare Figs. 6I and 3P–R). In contrast, in Streptomycin-damaged
cultures treated with DAPT for 3 days, Hes5 transcripts were markedly
attenuated (compare Figs. 6I with 6J). Similar changes were seen in the
lagena (data not shown).
These ﬁndings conﬁrm that DAPTefﬁciently blocks Notch signaling
in cultured BPs, and they serve as a positive control for DAPT
experiments in BPs without Streptomycin treatment, described above.
These results also show that inhibition of Notch signaling with either
DAPT or TAPI-1 during drug-induced HC damage does not block the
initiation of HC regeneration, as reﬂected by Atoh1 upregulation.
Rather, inhibition of Notch induces a large and rapid upregulation in
HC differentiation, suggesting that, just as during embryonic produc-
tion, the commitment of cells in the damaged BP to an HC fate is
limited by Delta/Notch-mediated lateral inhibition.
Inhibition of gamma secretase leads to overproduction of HCs at the
expense of SCs
Maintenance of cultures for longer periods conﬁrmed that HCs are
overproduced at the expense of SCs when Notch signaling is inhibited
after HC damage. Cultures grown for 8 days (2 days with Streptomycin
then 6 days without Streptomycin) with continuous DAPT showed a
dramatic increase in the density of regenerated HCs compared to
DMSO controls, as demonstrated by increased immunolabeling for
MyosinVI (compare Figs. 7A, B and 7D, E) and Hair Cell Antigen (HCA)
(Bartolami et al., 1991) (Figs. 7J, N). In this ﬁgure, BPs treated with
Fig. 7.DAPT treatment triggers overproduction of auditory HCs by direct transdifferentiation following drug-inducedHC loss. All images except I andMare Z-projections of the BP after
DMSO (0.5%; A–C, G–J) or DAPT (50 µM; D–F, K–N) treatment for 6 days after an initial 2-day Streptomycin treatment. In these images, the neural edge is toward the top, and the distal
end is toward the right. In A–F, vertical gray lines indicate the entire width of the BP, and vertical yellow lines show the extent of the neural region. (A, B) MyosinVI labeling shows the
pattern of HC regeneration in DMSO-treated BPs, in proximal (A) and middle (B) regions. (D, E) MyosinVI labeling reveals HC overproduction in DAPT-treated BPs in proximal (D) and
middle (E) regions. (C, F) SCA labeling (green) in the middle region reveals the distribution of differentiated SCs after DMSO (C) or DAPT (F) treatment; MyosinVI labeling (red)
demonstrates HC overproduction in the neural half. (G, K) Higher-magniﬁcation taken near the boxed regions in C and F. Arrow in K points to an SCA-positive SC(s). H, I, L, M. MyosinVI
labeling is shown inwhole-mounts (H, L) or vertical slices (I,M) through the neural half of DMSO- (H, I) or DAPT- (L,M) treated BPs. Arrowhead in I points to a regeneratedHC; arrows in
M point toMyosinVI-negative cells (presumed SCs). (J, N) HCA labeling in themiddle-neural region of DMSO- (J) orDAPT- (N) treated BPs is shown. Scale bar=50 µm for A–F,10 µm for G–N.
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HC density was accompanied by a decrease in SC density, as shown by
immunostaining for Supporting Cell Antigen, or SCA (Kruger et al.,
1999) (Figs. 7C,F) and for another SC-speciﬁc antigen that is likely a
precursor of β-Tectorin (Goodyear et al., 1996) (Supplemental Fig. 1).
In DMSO controls (Figs. 7G–J), regenerated HCs and SCs were evenly
mixed. In contrast, in DAPT-treated organs (Figs. 7K–N), regenerated
HCs were numerous, tightly packed, and appeared to be in direct
contact with one another, while SCs were uncommon and hapha-
zardly distributed. Similar results were consistently seen when: 1)
DAPT was used at 10, 50, or 100 µM; 2) cochlear ducts from 1 month-
old chickens were used; or 3) DAPTor DMSOwas added from the start
of culture or after the Streptomycin exposure (data not shown).
To assess if cell death might be a cause of the reduction in SC
proﬁles seen after DAPT treatment, we cultured BPs for shorter
periods (2 days plus Streptomycin followed by either 2 days or 4 days
of either 50 µM DAPT or 0.5% DMSO) and labeled them for TUNEL or
activated Caspase 3. While small numbers of dying cells were detected
in both DAPT and DMSO-treated samples, no qualitative difference in
labeling for either cell death marker was evident (data not shown).
These data suggest that the decrease in total cell number seen after
DAPT treatment is not due to increased cell death.We noted regional variations in the response to DAPT. Proximally,
DAPT caused a large increase in HC density across the entire width of
the epithelium (Fig. 7D), while in middle and distal regions, DAPT
caused this effect only in the neural half of the epithelium (Fig. 7E).
Thus, the regions showing the strongest signs of Notch pathway
activation following damage in vivo (see Figs. 3I, J, P–R) as well as the
highest degree of SC division (see Fig. 3H) show the strongest effects of
DAPT.
Constitutive Notch activation prevents SCs from forming new HCs
Our results show that inhibition of gamma secretase leads to
attenuation of Notch activity and increased regeneration of HCs at the
expense of SCs. While these ﬁndings strongly suggest that Notch
signaling is required to laterally inhibit cells from differentiating into
HCs after damage in the mature BP, gamma secretase cleaves a variety
of signaling proteins in addition to Notch (e.g., p75, Zampieri et al.,
2005), leaving open the possibility that other signaling molecules
besides Notch may have this critical role.
To directly test the role of Notch in maintaining the SC phenotype
after damage,we transfected SCs in cultured cochlear ductswith either
one of the plasmids encoding the activating portion of the Notch
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plasmid (encoding EGFP only), and examined SC behavior in each case.
Cochlear ducts were cultured for 2 days with Streptomycin to kill HCs,
and plasmid was transfected into some of the remaining SCs using
electroporation. Culturesweremaintained for twoor 5 additional days,
and were then ﬁxed, immunolabeled to detect MyosinVI and GFP, and
examined to determine the fate of transfected SCs.
Two days after transfectionwith either plasmid, MyosinVI-positive
cells (HCs) were rare, since original HCs had been killed and few new
HCs had been regenerated (Fig. 8A, a pMES-transfected BP is shown).
The majority of transfected, GFP-immunoreactive (IR) cells still had
SC-like morphology, with elongated cell bodies and thin cytoplasmic
processes extending from the nuclear region. At 5 days post-
transfection, BPs transfected with either pMES or pNICD contained
MyosinVI-positive, regenerated HCs (Figs. 8C, F). We scored GFP-IR
cells in pMES- or pNICD-transfected BPs at this time as either
MyosinVI-positive (HC-like) or MyosinVI-negative (SC-like). In
pMES-transfected BPs, a signiﬁcantly higher percentage of GFP-IR
cells were MyosinVI-positive (25.4%) than in pNICD-transfected BPs
(2.0%) (pb0.0001) (Fig. 8B). We also found that GFP-IR cells that were
MyosinVI-positive usually had a round or fusiform cell shape,
characteristic of well differentiated HCs, while GFP-IR cells lacking
MyosinVI IR were usually SC-like (Figs. 8C–H). This observation
provided additional support for the use of MyosinVI labeling to deﬁneFig. 8.Overexpression of NICD prevents SCs from directly converting into HCs after damage. T
images from BPs at 2 days (A) or 5 days (C–H) after transfection of negative control plasmid
2 days after transfectionwith pMES have SC-like features (long cytoplasmic processes [arrow
cultures at 5 days post-transfection (C–H). (C–E) GFP-positive cells at 5 days after transfect
round) or an SC-like morphology. (F–H) The vast majority of GFP-positive cells at 5 days aft
separate channels in D, E and G, H, respectively. Scale bar=20 µm.a cell as HC-like or SC-like. These data conﬁrmed that increased Notch
activity in mature avian SCs is sufﬁcient to prevent them from
generating new HCs or to instruct them to maintain an SC phenotype
after HC loss. Further, these ﬁndings provide further support that the
DAPT effects seen in experiments described above are due to
inactivation of Notch signaling.
Moderate doses of gamma secretase inhibitor cause HC overproduction
after damage without signiﬁcantly affecting cell division
We next examined how cell division after damage is affected by
DAPT, and how this might relate to the overproduction of HCs.
Cochlear ducts were cultured with Streptomycin for 2 days followed
by 6 days with DAPT (50 µM) or with 0.5% DMSO. BrdU was provided
continuously. For these experiments, we used Atoh1 protein as a
marker of regenerated HCs rather than MyosinVI. Atoh1 immuno-
reactivity is detected in differentiating HCs between 5 and 10 days
post-Gentamicin, much like MyosinVI (Cafaro et al., 2007).
Organs were ﬁxed and double-labeled for BrdU and Atoh1, and
BrdU and Atoh1 labeling were quantiﬁed. We found that the number
of regenerated HCs (per unit area of epithelium) was roughly two-fold
higher in DAPT-treated BPs than in DMSO controls (224 ±95 s.d. for
DAPT versus 116 ±21 s.d. for DMSO, p =0.0072) (Figs. 9A, B insets;
MyosinVI labeling in parallel experiments are shown in main panelshis ﬁgure shows representative GFP-positive cells (green) in brightest point Z-projection
(pMES) or pNICD. Counterlabeling for MyosinVI is shown in red. (A) GFP-positive cells at
heads] that are MyosinVI-negative; arrow points to nucleus). (B) Quantitative data from
ion with pMES have either an HC-like morphology (MyosinVI-positive and fusiform or
er transfection with pNICD have an SC-like morphology. Images in C and F are shown in
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numbers of both BrdU-positive (Fig. 9G) and BrdU-negative HCs
(Fig. 9H), although the latter effect was not statistically signiﬁcant. The
50 µMDAPT did not, however, cause any signiﬁcant change in the total
numbers of BrdU-labeled nuclei compared to controls (Fig. 9E). These
results show that 50 µM DAPT does not alter the amount of SC
division, but it does cause a higher proportion of SCs and progeny of
SCs to differentiate as HCs.
We also, in a separate run of the experiment, using MyosinVI as
marker of new HCs, tested the effects of a still higher dose of DAPT:Fig. 9. DAPT favors HC differentiation, and at the highest dose, can also limit SC division. (A–D
BPs treated with 0.5% DMSO (A), or 50 µM DAPT (B), 1% DMSO (C), 100 µM DAPT (D). In each
throughout. BrdU immunolabeling is shown in green in all images, whileMyosinVI immunola
A and B. Arrows in A–C point to post-mitotic regenerated HCs, which are double-labeled fo
BrdU-negative (−). In the insets, cells that are double-labeled for Atoh1 and BrdU have oran
analysis of cell division. Graphs show the density of BrdU+ nuclei measured in BPs treatedwit
with 100 µM DAPT or 1% DMSO (F). G–J. Quantitative analysis of HC differentiation. (G, H) The
density of MyosinVI+/BrdU− cells (newHCs formed by direct transdifferentiation) (H) measu
MyosinVI+/BrdU+ cells (new post-mitotic HCs) (I) or the density of MyosinVI+/BrdU− cells (n
DAPT or 1% DMSO. For all graphs, density=number of cells per 41,209 µm2. All error bars ar100 µM. This is at or over the limit of solubility of DAPT, making it
prone to precipitate out of solution and raising concerns about non-
speciﬁc toxic effects. Organs were ﬁxed as in the foregoing experiment
and double-labeled for BrdU and MyosinVI, and BrdU and MyosinVI
labeling were quantiﬁed. As with the 50 µM dose of DAPT, the number
of new HCs was much higher in DAPT-treated BPs than in DMSO
controls (112 ±34 s.d for DAPT versus 40 ±13 s.d. for DMSO,
p b0.0001) (Figs. 9C, D). However, the BPs treated with 100 µM
DAPT showed a striking decrease in the numbers of cells labeled with
BrdU (Fig. 9F; p b0.0001). Correspondingly, very few of the HCs) These images show single confocal slices through the HC layer in the neural region of
case, 2 days of Streptomycin were followed by 6 days in DAPT/DMSO, with BrdU present
beling is shown in red in A–D and Atoh1 immunolabeling is shown in red in the insets in
r BrdU and MyosinVI. The arrowhead in D points to a MyosinVI-positive (+) cell that is
ge nuclei, while those that are Atoh1+ and BrdU− have red nuclei. (E, F) Quantitative
h 50 µMDAPTor 0.5% DMSO (E) and the density of BrdU+ nuclei measured in BPs treated
se graphs show the density of MyosinVI+/BrdU+ cells (new post-mitotic HCs) (G) or the
red in BPs treated with 50 µMDAPTor 0.5% DMSO. (I, J) These graphs show the density of
ew HCs formed by direct transdifferentiation) (J) measured in BPs treated with 100 µM
e s.d.'s. Scale bar (in A)=10 µm for A–D, 22 µm for insets in A and B.
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(Fig. 9I); rather, the vast majority of themwere BrdU-negative (Fig. 9J).
These results show that 100 µM DAPT, like 50 µM DAPT, biases SCs
toward differentiation as HCs during regeneration; but, they also
indicate that the very high dose of DAPT has an additional effect, not
seen at lower doses, in decreasing cumulative cell division. This anti-
proliferative effect could reﬂect a general toxicity independent of
Notch signaling. Indeed, as the next experiments show, it was not
always seen, even with the 100 µM DAPT dose.
Notch signaling exerts no direct inﬂuence on SC entry into the cell cycle
To examine possible effects on cell division in greater detail, we
examined whether acute treatment with DAPT after Streptomycin
treatment prevents SCs from entering the cell cycle in the short term.
Organs were cultured for 3 days (2 days plus Streptomycin then 1 day
without Streptomycin). DAPT (100 µM) or DMSO (1%) was present for
the entire culture period, and BrdU was added for the last 4 h before
ﬁxation. This early DAPT treatment allowed us to assess effects of
DAPT on the initial rise in SC division, which is seen at 3 days in vitro.
We detected no signiﬁcant difference in the numbers of BrdU-positive
nuclei between the two groups (26 ±14 s.d. for DMSO and 32 ±16 s.d.
for DAPT, N =3 BPs for each group, p =0.4037) nor in the neural focus
of SC division (data not shown), indicating that 100 µM DAPT did not
inhibit SC recruitment into the cell cycle in this set of experiments.
We also examined whether Notch activity is required after SCs
have entered the cell cycle to sustain mitotic activity. Organs were
cultured for 5 days (2 days plus Streptomycin then 3 days without
Streptomycin), with 100 µM DAPT or DMSO present for the ﬁnal
2 days, and BrdU present for the ﬁnal 24 h. A longer BrdU pulse was
provided here than for 3-day experiments, because we anticipated a
decline in the number of normally dividing SCs over time (Stone et al.,
1999). We noted no difference in the distribution or density of BrdU-
positive nuclei between the two groups (47 ±49 for DMSO and 45 ±32
for DMSO, N =3 BPs for each group, p =0.9223), demonstrating that
Notch activity is not required to maintain SC division after it is
initiated.
Discussion
Despite the discovery of HC regeneration in the mature avian
auditory epithelium (BP) 20 years ago, the molecular cues that
regulate activation of mature SCs are still largely uncharacterized. We
have shown that, in the undamaged BP, Notch signaling is not
responsible for inhibiting SCs from dividing or from directly
transdifferentiating into HCs. Another set of signals must exert these
effects. However, during regeneration after HC loss, Notch activity has
a key role in limiting the number of new HCs that are generated
through either mitosis or direct transdifferentiation of SCs. In the
following discussion, we explain these ﬁndings in more detail and
consider their implications for the logic of signals governing HC
regeneration.
Changes in Notch signaling are not the trigger for regeneration
In the post-hatch avian BP, SCs are a quiescent population unless
HC loss occurs. It has been hypothesized that direct contact from HCs
maintains SC quiescence (Corwin et al., 1991; and Cotanche, 1987).
This could in theory be mediated by lateral inhibition that is
dependent upon Notch ligands expressed by mature HCs (Lewis,
1991). Indeed, we show here that at least two Notch receptors (Notch1
and Notch2), three ligands (Delta1, Serrate1, and Serrate2), and one
effector (Hes5) are transcribed in the undamaged BP. However,
expression of these Notch pathway components does not necessarily
imply functional importance, and we have found that blockade of
Notch signaling by DAPT in undamaged BPs is not sufﬁcient to triggerSCs to convert into HCs or to divide. This ﬁnding is in agreement with
two recent studies in other species. Ma et al. (2008) and Hori et al.
(2007) showed that inhibition of gamma secretase using either DAPT
or MDL does not induce HC production in undamaged lateral line
neuromasts of larval zebraﬁsh or in undamaged adult organ of Corti,
respectively. In contrast, two other studies (Takebayashi et al., 2007;
and Yamamoto et al., 2006) showed that DAPT treatment in late
embryonic organ of Corti of undamaged mice causes SCs to de-
differentiate and to convert into HCs. The key to these differences may
be the relative maturity of SCs. Our study and the studies by Ma et al.
(2008) and Hori et al. (2007) were performed in mature HC-epithelia,
whereas the studies by Yamamoto et al. (2006) and Takebayashi et al.
(2007) were performed in HC-epithelia that will not reach full
maturity until 1–3 weeks later (e.g., Sher, 1971; and Tannenbaum and
Slepecky, 1997). Considering these studies together with our present
data, we conclude that, whereas Notch signaling is needed to establish
the phenotype of SCs and to limit HC production during development,
other mechanisms take over the role of maintaining the quiescent SC
phenotype once the sensory epithelium has matured. We discuss this
point further below.
Another key ﬁnding of this study is that inhibition of Notch
signaling with DAPT or TAPI-1 does not prevent HC regeneration from
occurring in the BP in culture. Therefore, we conclude that Notch
activity is not required for SCs to transit from quiescence to a state of
activation, either for renewed cell division or direct transdifferentia-
tion, following HC damage.
Following tissue damage, Notch-mediated lateral inhibition inhibits the
differentiation of hair cells formed by either mitosis or
direct transdifferentiation
Although a change in Notch signaling is not the trigger for the
regenerative response in the chicken BP, our data show that Notch
does play a key role in directing the course of that response, once HC
damage is initiated. In fact, HC loss from the post-hatch BP appears to
restore the epithelium to a state resembling the developing otic
epithelium as HCs are emerging: the embryonic pattern of expression
of Notch pathway components is reconstituted, and Notch signaling is
reactivated.
There are several distinct functions that Notch signaling might
perform in the regenerative process. At early stages of development,
before HC differentiation has begun, Notch activity serves in the
developing inner ear to establish and/or to extend the prosensory
patches (Kiernan et al., 2006; Daudet et al., 2007; and Hayashi et al.,
2008). We therefore considered the possibility that re-activation of
Notch signaling might be necessary to initiate regeneration in the
chicken BP. However, DAPT treatment before and during HC damage
did not block the regenerative response, demonstrating that this is not
the case.
Notch signaling also directs cell fate decisions during development
via lateral inhibition. During this process, Atoh1 acts upstream of
Delta1, while Notch activity inhibits expression of Atoh1 and Delta1
(and Serrate2/Jagged2). Cells that express Atoh1 and Delta1 become
HCs, and by activating Notch in their neighbors, they prevent their
neighbors from becoming HCs and ensure that they remain as sensory
progenitor cells or differentiate as SCs (Lanford et al., 2000; and
Millimaki et al., 2007). A similar control system evidently operates
during HC regeneration in the chicken BP. Levels of Atoh1 protein
increase by 1 day post-Gentamicin (Cafaro et al., 2007), followed by a
rise in Delta1 transcript levels (Stone and Rubel, 1999). Experimental
blockade of Notch activity with DAPT induced a strong increase in the
expression of both Atoh1 and Delta1 in short-term cultures. In long-
term cultures, DAPT caused the overproduction of HCs, via mitotic and
non-mitotic mechanisms, at the expense of SCs. Overexpression of
activated Notch (NICD) had the opposite effect; it maintained the SC
phenotype. Collectively, our results strongly suggest that negative
99N. Daudet et al. / Developmental Biology 326 (2009) 86–100regulation of Atoh1 and Delta1 by lateral inhibition governs HC
differentiation during regeneration, as it does during development,
but that some factor beside reduced Notch activity triggers the initial
rise of Atoh1 expression following HC destruction.
After HC loss in the chicken BP, Delta1 mRNA is detected in BrdU-
labeled cells, suggesting that HCs formed through renewed cell
division inhibit neighboring cells from differentiating as HCs (Stone
and Rubel, 1999).
Notch activity is not a direct regulator of cell division in the
regenerating BP
Normal regeneration in the BP involves resumption of cell division
as well as switches of cell differentiation. Our data clearly show that
Notch signaling governs the switches of cell differentiation. Does it
also govern cell division? Given that HCs do not divide but SCs can,
onemight expect that activation of the Notch pathway, by blocking HC
differentiation, would favor proliferation. We found, on the contrary,
that expression of Hes5, indicative of Notch activation, was inversely
correlated with BrdU labeling, suggesting that if Notch signaling has
any effect on cell division, it is inhibitory. Moreover, moderate doses of
DAPT, while strongly favoring HC differentiation, and thus evidently
sufﬁcient to block Notch signaling, had no signiﬁcant effect on the
fraction of cells entering the division cycle. In acute experiments, even
the very highest dose of DAPT (100 µM) had no effect on the numbers
of cells entering S-phase. However, in one set of long-term experi-
ments involving DAPT exposure at this maximal level, we did see a
strong reduction of BrdU labeling. This result was not replicated with
lower DAPT levels. This reduction in BrdU labeling may be a Notch-
independent toxic side-effect of high-dose DAPT. Alternatively, it may
reﬂect an actual long-term reduction in SC division that occurred
because the high-dose DAPT triggered a massive conversion of SCs
into HCs by direct transdifferentiation and depletion of SCs. However,
this is hard to reconcile with the rest of the data. The more likely
interpretation seems to be that cell division during regeneration is
controlled by some inﬂuence other than Notch signaling.
Two types of signals control the behavior of supporting cells:
one delivered via Notch, the other independent of Notch
If Notch activity is not required to keep SCs quiescent in the
undamaged state or to regulate their ability to divide following HC
damage, then what are the signals that regulate these important SC
behaviors? Our working hypothesis is that HCs deliver two types of
inhibitory signals to their neighbors. The ﬁrst type, the Quiescence (Q)
signal, is independent of Notch, functions during quiescence and
regeneration, and inhibits SCs from directly transdifferentiating into
HCs and from dividing. The second signal, the Notch (N) signal, is
necessary for normal embryonic development and during regenera-
tion, but it does not maintain quiescence or directly control cell
division. Rather, its function after HC damage is to limit, via lateral
inhibition, the proportion of SCs and SC progeny that differentiate into
HCs. A corollary of our two-signal hypothesis is that Q and N signals
act in parallel to restrict HC differentiation. Depending on the relative
timing and intensity of their actions, one signal or the other might
predominate. This could explain differences that we saw in regen-
erative behavior and in the response to DAPT of SCs on the neural and
abneural sides of the BP.
What is the molecular basis of the Q signal? One suggestion is that
it might take the form of a cadherin-mediated interaction between
HCs and their neighbors (Warchol, 2002). Other cell-surface signaling
molecules, such as Ephrins and Eph family members, are also
candidates for such a role, as are soluble factors, such as those of the
Wnt, FGF, and BMP families. The nature of the signal(s) that initiate
regeneration and control the proliferation of SCs is a central problem
for future research.Acknowledgments
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